Specialty Ophthalmology
-
Featured
Association Between Female Reproductive Factors and Risk of Exfoliation Glaucoma or Glaucoma Suspect
In a large prospective cohort study of women followed for 30 years, Jae Hee Kang, ScD, Janey Wiggs, MD, PhD, and collaborators at Brigham and Women’s Hospital show a relationship between female reproductive factors and exfoliation glaucoma/glaucoma suspect, suggesting increased risk with greater lifetime estrogen exposure.
-
IRIS Registry Analysis Explores Epidemiology, Clinical Features, and Visual Outcomes after Intraocular Foreign Body Removal
Ines Lains, MD, PhD, and colleagues at Mass Eye and Ear, in collaboration with Moorfields Eye Hospital, London, studied presentation and visual outcomes after intraocular foreign body (IOFB) injuries–rare but vision-threatening emergencies–using a large multicenter clinical registry to inform risk prognosis and care.
-
Cultivated Autologous Limbal Epithelial Cell Transplantation Is Promising for Managing Limbal Stem Cell Deficiency
Ula V. Jurkunas, MD, and colleagues present imaging data indicating that cultivated autologous limbal epithelial cell transplantation, their novel procedure for patients with limbal stem cell deficiency, improves epithelial basal cell density and the proportion of corneal epithelial cells in the central cornea.
-
Pharmacological Innovations in Ophthalmology: The Development of Photodynamic Therapy and Anti-Vascular Endothelial Growth Factor
Joan W. Miller, MD, looks back at how a skin cancer treatment inspired her and a team of researchers to develop a more selective and effective treatment for choroidal neovascularization, and how that same team worked together to identify the key role of VEGF in ocular neovascularization, leading to the development of anti-VEGF therapies.
-
Liver-directed Therapy Offers Effective Treatment for Rare Metastatic Uveal Melanoma
Physicians at Massachusetts General Hospital are providing access to percutaneous hepatic perfusion as an effective treatment for uveal melanoma liver metastases.
-
Mass Eye and Ear Sets Standards of Transparency and Accountability in Ophthalmology
The Department of Ophthalmology at Massachusetts Eye and Ear/Massachusetts General Hospital leads the ophthalmology community in developing and implementing outcome measures in every subspecialty area—setting the standard for transparency, accountability, and continued quality improvement in the field.
Ophthalmology Contributors
-
Alice C. Lorch, MD, MPH
Assistant Professor of Ophthalmology, Harvard Medical School, Associate Chief for Quality for the Department of Ophthalmology, Mass Eye and Ear, Director, Harvard Ophthalmology Residency Training Program
Recent Article
Usage Patterns of Minimally Invasive Glaucoma Surgery Differ by Glaucoma Type
-
Bruce Ksander, PhD
Associate Professor of Ophthalmology, Harvard Medical School, Associate Scientist, Mass Eye and Ear
Recent Article
Turning Back the Clock on Aged Eye Cells
-
Janey L. Wiggs, MD, PhD
Associate Chief, Ophthalmology Clinical Research, Mass Eye and Ear, Paul Austin Chandler Professor of Ophthalmology, Harvard Medical School
Recent Article
Association Between Female Reproductive Factors and Risk of Exfoliation Glaucoma or Glaucoma Suspect
-
Joan W. Miller, MD
Chief, Ophthalmology Department, Massachusetts General Hospital, Chief, Ophthalmology Department, Mass Eye and Ear, Ophthalmologist-in-Chief, Brigham and Women’s Hospital
Recent Article
Pharmacological Innovations in Ophthalmology: The Development of Photodynamic Therapy and Anti-Vascular Endothelial Growth Factor
-
John B. Miller, MD
Clinician–Investigator, Yeatts Retina Research Laboratory, Mass Eye and Ear, Member, Diabetic Eye Disease Center of Excellence, Assistant Professor of Ophthalmology, Harvard Medical School
Recent Article
Non-invasive OCTA Imaging Biomarker Tied to Neovascular Glaucoma in Patients With Proliferative Diabetic Retinopathy
-
Lucia Sobrin, MD, MPH
Associate Chief of Clinical Data Science and Director of the Morse Laser Center, Mass Eye and Ear, Associate Professor of Ophthalmology, Harvard Medical School, Co-Director, Ocular Immunology and Uveitis Fellowship
Recent Article
Younger Age, Albuminuria Linked to Advanced Diabetic Retinopathy in South India
-
Luk Vandenberghe, PhD
Associate Professor of Ophthalmology, Harvard Medical School, Grousbeck Family Chair in Gene Therapy and Director of the Grousbeck Gene Therapy Center, Mass Eye and Ear
Recent Article
Developing a Gene-based Vaccine Candidate for COVID-19
-
Meredith Gregory-Ksander, PhD
Associate Scientist, Schepens Eye Research Institute, Mass Eye and Ear, Assistant Professor of Ophthalmology, Harvard Medical School
Recent Article
Turning Back the Clock on Aged Eye Cells
-
Milica Margeta, MD, PhD
Assistant Professor of Ophthalmology, Harvard Medical School, Assistant Scientist, Mass Eye and Ear
Recent Article
Genetic Risk Factor for Alzheimer's Disease Linked to Reduced Glaucoma Risk
-
Nazlee Zebardast, MD, MSc
Director, Glaucoma Imaging, Mass Eye and Ear/Massachusetts General Hospital Department of Ophthalmology, Assistant Professor, Ophthalmology, Harvard Medical School
Recent Article
Usage Patterns of Minimally Invasive Glaucoma Surgery Differ by Glaucoma Type
-
Tobias Elze, PhD
Assistant Professor of Ophthalmology, Harvard Medical School, Assistant Scientist, Mass Eye and Ear
Recent Article
Usage Patterns of Minimally Invasive Glaucoma Surgery Differ by Glaucoma Type
-
Ula V. Jurkunas, MD
Associate Director, Cornea Service, Mass Eye and Ear, Professor of Ophthalmology, Harvard Medical School
Recent Article
Cultivated Autologous Limbal Epithelial Cell Transplantation Is Promising for Managing Limbal Stem Cell Deficiency
Mass Eye and Ear/Mass General Ophthalmology
An international center for ophthalmology treatment and research, Mass Eye and Ear/Massachusetts General Hospital is the primary teaching hospital of Harvard Medical School’s Department of Ophthalmology, and is consistently recognized as one of the nation’s top hospitals for eye care. Led by Chief and Chair Joan W. Miller, MD, the department provides seamless access to the most innovative care available anywhere in the world.